EW Edwards Lifesciences Corp

$81.83

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Edwards Lifesciences Corp

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

Website: https://www.edwards.com

Sector
LIFE SCIENCES
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1099800
Address
ONE EDWARDS WAY, IRVINE, CA, US
Valuation
Market Cap
$41.90B
P/E Ratio
30.57
PEG Ratio
4.30
Price to Book
4.19
Performance
EPS
$2.34
Dividend Yield
—
Profit Margin
76.70%
ROE
16.60%
Technicals
50D MA
$71.28
200D MA
$71.23
52W High
$95.25
52W Low
$58.93
Fundamentals
Shares Outstanding
586M
Target Price
$79.48
Beta
1.15

EW EPS Estimates vs Actual

● Estimated
● Actual

EW News & Sentiment

Aug 20, 2025 • Benzinga SOMEWHAT-BULLISH
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today - Edwards Lifesciences ( NYSE:EW )
Edwards Lifesciences EW has outperformed the market over the past 15 years by 2.56% on an annualized basis producing an average annual return of 15.33%. Currently, Edwards Lifesciences has a market capitalization of $47.73 billion.
Aug 14, 2025 • Benzinga NEUTRAL
Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm - Edwards Lifesciences ( NYSE:EW )
Investors can contact the law firm at no cost to learn more about recovering their losses
Aug 14, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Abbott Taps Growing TMVR Market With Tendyne System
ABT wins FDA nod for its Tendyne TMVR system, offering a minimally invasive option for patients with severe mitral valve disease.
Aug 13, 2025 • Benzinga NEUTRAL
EDWARDS ( EW ) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Edwards Lifesciences ( NYSE:EW )
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Edwards ( EW ) To Contact Him Directly To Discuss Their Options
Aug 11, 2025 • Motley Fool SOMEWHAT-BULLISH
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
A longtime leader in financial services tops the list.
Aug 08, 2025 • Benzinga NEUTRAL
Deal Dispatch: Performance Food Rejects Offer, Claire's Bankrupt - American Woodmark ( NASDAQ:AMWD ) , Boeing ( NYSE:BA )
Performance Food rejects offer; Bachan's, Hg and Yomeishu explore sales; Lufthansa drops Air Europa bid; NFL sells media to ESPN Skydance Media finally completed its $8-billion acquisition of Paramount Global. Sen. Warren called it a "wink, wink" arrangement.
Sentiment Snapshot

Average Sentiment Score:

0.173
50 articles with scored sentiment

Overall Sentiment:

Bullish

EW Reported Earnings

Apr 23, 2025
Mar 31, 2025 (Pre market)
0.04 Surprise
  • Reported EPS: $0.64
  • Estimate: $0.60
  • Whisper: —
  • Surprise %: 7.5%
Feb 04, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.59
  • Estimate: $0.55
  • Whisper: —
  • Surprise %: 6.4%
Oct 24, 2024
Sep 30, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $0.67
  • Estimate: $0.64
  • Whisper: —
  • Surprise %: 4.7%
Jul 24, 2024
Jun 30, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $0.70
  • Estimate: $0.69
  • Whisper: —
  • Surprise %: 1.4%
Apr 25, 2024
Mar 31, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.66
  • Estimate: $0.64
  • Whisper: —
  • Surprise %: 3.1%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.0 Surprise
  • Reported EPS: $0.64
  • Estimate: $0.64
  • Whisper: —
  • Surprise %: 0.0%
Oct 25, 2023
Sep 30, 2023 (Post market)
0.0 Surprise
  • Reported EPS: $0.59
  • Estimate: $0.59
  • Whisper: —
  • Surprise %: 0.0%
Jul 26, 2023
Jun 30, 2023 (Post market)
0.01 Surprise
  • Reported EPS: $0.66
  • Estimate: $0.65
  • Whisper: —
  • Surprise %: 1.5%
Apr 26, 2023
Mar 31, 2023 (Post market)
0.01 Surprise
  • Reported EPS: $0.62
  • Estimate: $0.61
  • Whisper: —
  • Surprise %: 1.6%

Financials